O'Donovan Eimear Mary, Sanchez-Lechuga Begona, Prehn Emma, Byrne Maria Michelle
1Department of Endocrinology, Mater Misericordiae University Hospital, Dublin, Ireland.
Endocrinol Diabetes Metab Case Rep. 2022 Jul 1;2022. doi: 10.1530/EDM-21-0212.
The coexistence of autoimmune diabetes and maturity-onset diabetes (MODY) is rare. The absence of pancreatic autoantibodies is a key factor prompting MODY genetic testing. In this study, we report three cases of young-onset diabetes with progressive beta-cell dysfunction, strongly positive glutamic acid decarboxylase (GAD) antibodies, and genetic confirmation of pathogenic gene variants of HNF-1A, HNF-4A, and ABCC8-MODY. The first case is a woman diagnosed with HNF-1A-MODY diabetes more than 30 years after her diagnosis of adult-onset diabetes at 25 years. She required insulin after her fourth pregnancy. She became ketotic on oral hypoglycaemic agents (OHAs) and subsequently, her GAD antibodies tested positive. The second case is a woman diagnosed with diabetes at 17 years who was subsequently diagnosed with HNF-4A-MODY after many hypoglycaemic episodes on low-dose insulin. GAD antibodies were strongly positive. The last case is a man diagnosed with diabetes at 26 years who was well controlled on OHAs and required insulin years later due to sudden deterioration in glycaemic control. His ABCC8-MODY was diagnosed upon realisation of strong family history and his GAD antibodies tested positive. All subjects are now treated with insulin. Less than 1% of subjects with MODY have positive autoantibodies. These cases highlight individuals who may have two different types of diabetes simultaneously or consecutively. Deterioration of glycaemic control in subjects with MODY diabetes should highlight the need to look for the emergence of autoantibodies. At each clinic visit, one should update the family history as MODY was diagnosed in each case after the development of diabetes in their offspring.
These cases highlight the rare coexistence of autoimmune diabetes and MODY. Deterioration of glycaemic control in subjects with MODY diabetes should highlight the emergence of autoantibodies. One should revise and update the family history as the diagnosis of MODY was made after the development of diabetes in offspring. Understanding the spectrum of diabetes allows for precision medicine.
自身免疫性糖尿病与成年发病型糖尿病(MODY)并存的情况较为罕见。缺乏胰腺自身抗体是促使进行MODY基因检测的关键因素。在本研究中,我们报告了三例年轻发病型糖尿病患者,他们伴有进行性β细胞功能障碍、谷氨酸脱羧酶(GAD)抗体强阳性,并且通过基因检测证实存在HNF-1A、HNF-4A和ABCC8-MODY的致病基因变异。第一例是一名女性,25岁时被诊断为成年发病型糖尿病,30多年后被诊断为HNF-1A-MODY糖尿病。她在第四次怀孕后需要胰岛素治疗。她在口服降糖药(OHA)治疗期间出现酮症,随后GAD抗体检测呈阳性。第二例是一名17岁被诊断为糖尿病的女性,在使用小剂量胰岛素多次发生低血糖事件后,随后被诊断为HNF-4A-MODY。GAD抗体强阳性。最后一例是一名26岁被诊断为糖尿病的男性,他在OHA治疗下病情控制良好,但多年后由于血糖控制突然恶化而需要胰岛素治疗。在意识到其家族病史后,他被诊断为ABCC8-MODY,其GAD抗体检测呈阳性。所有受试者目前均接受胰岛素治疗。不到1%的MODY患者自身抗体呈阳性。这些病例突出了可能同时或相继患有两种不同类型糖尿病的个体。MODY糖尿病患者血糖控制恶化应提示需关注自身抗体的出现。每次门诊就诊时,都应更新家族病史,因为在这些病例中,MODY都是在其后代患糖尿病后才被诊断出来的。
这些病例突出了自身免疫性糖尿病与MODY罕见的并存情况。MODY糖尿病患者血糖控制恶化应提示自身抗体的出现。由于MODY是在后代患糖尿病后才被诊断出来的,因此应修订和更新家族病史。了解糖尿病的谱系有助于实现精准医疗。